<?xml version="1.0" encoding="UTF-8"?>
<p>In Malawi and Zambia, the expansion of universal HIV treatment for pregnant and breastfeeding women (i.e., “Option B+”) has greatly increased access to antiretroviral therapy among HIV-positive women. In 2018, UNAIDS reported that both country programs reached national coverage rates of 95% [
 <xref rid="pone.0223487.ref002" ref-type="bibr">2</xref>], an important milestone for HIV treatment programs globally [
 <xref rid="pone.0223487.ref037" ref-type="bibr">37</xref>]. Given the demands of establishing and maintaining such successful programs, concerns about the sustainability of new HIV prevention services—built upon the same antenatal platforms—were not surprising. Policymakers articulated a need for prioritization within HIV prevention and treatment services, emphasizing the need for sustainability in the context of donor funding.
</p>
